Myeloproliferative neoplasm surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Shyam Patel [3]

Overview

Surgical intervention is usually not recommended for the management of chronic myelogenous leukemia, unless there is splenomegaly.

Surgery

Surgical intervention is rarely recommended for the management of chronic myelogenous leukemia in case of splenomegaly.^[1] There is generally no role for surgery.

References

↑ Santos FP, Tam CS, Kantarjian H, Cortes J, Thomas D, Pollock R; et al. (2014). “Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation”. Leuk Lymphoma. 55 (1): 121–7. doi:10.3109/10428194.2013.794269. PMC 3874259. PMID 23573823.

Template:WH Template:WS

[pmid23573823-1] Santos FP, Tam CS, Kantarjian H, Cortes J, Thomas D, Pollock R; et al. (2014). “Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation”. Leuk Lymphoma. 55 (1): 121–7. doi:10.3109/10428194.2013.794269. PMC 3874259. PMID 23573823.

[1]